ANTI-PDL1 x EGFR BISPECIFIC ANTIBODY
Provided is an anti-PDL1×EGFR bispecific antibody. Experimental results show that the bispecific antibody can maintain relatively well the activity of anti-EGFR and anti-PD-L1 monoclonal antibodies; in addition, same can specifically bind to the two PD-L1 and EGFR targets at the same time, and more...
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | GU, Changling Huang, Haomin ZHU, Zhenping ZHU, Haixia |
| description | Provided is an anti-PDL1×EGFR bispecific antibody. Experimental results show that the bispecific antibody can maintain relatively well the activity of anti-EGFR and anti-PD-L1 monoclonal antibodies; in addition, same can specifically bind to the two PD-L1 and EGFR targets at the same time, and more importantly, said bispecific antibody has obvious synergy at the cellular level. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2023257465A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2023257465A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2023257465A13</originalsourceid><addsrcrecordid>eNrjZFBx9Avx1A1w8TFUqFBwdXcLUnDyDA5wdfZ083RWAMk5-btE8jCwpiXmFKfyQmluBmU31xBnD93Ugvz41OKCxOTUvNSS-NBgIwMjYyNTcxMzU0dDY-JUAQDsrSO4</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>ANTI-PDL1 x EGFR BISPECIFIC ANTIBODY</title><source>esp@cenet</source><creator>GU, Changling ; Huang, Haomin ; ZHU, Zhenping ; ZHU, Haixia</creator><creatorcontrib>GU, Changling ; Huang, Haomin ; ZHU, Zhenping ; ZHU, Haixia</creatorcontrib><description>Provided is an anti-PDL1×EGFR bispecific antibody. Experimental results show that the bispecific antibody can maintain relatively well the activity of anti-EGFR and anti-PD-L1 monoclonal antibodies; in addition, same can specifically bind to the two PD-L1 and EGFR targets at the same time, and more importantly, said bispecific antibody has obvious synergy at the cellular level.</description><language>eng</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS THEREOF ; CULTURE MEDIA ; ENZYMOLOGY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; MICROBIOLOGY ; MICROORGANISMS OR ENZYMES ; MUTATION OR GENETIC ENGINEERING ; ORGANIC CHEMISTRY ; PEPTIDES ; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ; SPIRITS ; VINEGAR ; WINE</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230817&DB=EPODOC&CC=US&NR=2023257465A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76419</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230817&DB=EPODOC&CC=US&NR=2023257465A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>GU, Changling</creatorcontrib><creatorcontrib>Huang, Haomin</creatorcontrib><creatorcontrib>ZHU, Zhenping</creatorcontrib><creatorcontrib>ZHU, Haixia</creatorcontrib><title>ANTI-PDL1 x EGFR BISPECIFIC ANTIBODY</title><description>Provided is an anti-PDL1×EGFR bispecific antibody. Experimental results show that the bispecific antibody can maintain relatively well the activity of anti-EGFR and anti-PD-L1 monoclonal antibodies; in addition, same can specifically bind to the two PD-L1 and EGFR targets at the same time, and more importantly, said bispecific antibody has obvious synergy at the cellular level.</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS THEREOF</subject><subject>CULTURE MEDIA</subject><subject>ENZYMOLOGY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MICROORGANISMS OR ENZYMES</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><subject>SPIRITS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZFBx9Avx1A1w8TFUqFBwdXcLUnDyDA5wdfZ083RWAMk5-btE8jCwpiXmFKfyQmluBmU31xBnD93Ugvz41OKCxOTUvNSS-NBgIwMjYyNTcxMzU0dDY-JUAQDsrSO4</recordid><startdate>20230817</startdate><enddate>20230817</enddate><creator>GU, Changling</creator><creator>Huang, Haomin</creator><creator>ZHU, Zhenping</creator><creator>ZHU, Haixia</creator><scope>EVB</scope></search><sort><creationdate>20230817</creationdate><title>ANTI-PDL1 x EGFR BISPECIFIC ANTIBODY</title><author>GU, Changling ; Huang, Haomin ; ZHU, Zhenping ; ZHU, Haixia</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2023257465A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2023</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS THEREOF</topic><topic>CULTURE MEDIA</topic><topic>ENZYMOLOGY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MICROORGANISMS OR ENZYMES</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><topic>SPIRITS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>GU, Changling</creatorcontrib><creatorcontrib>Huang, Haomin</creatorcontrib><creatorcontrib>ZHU, Zhenping</creatorcontrib><creatorcontrib>ZHU, Haixia</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>GU, Changling</au><au>Huang, Haomin</au><au>ZHU, Zhenping</au><au>ZHU, Haixia</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>ANTI-PDL1 x EGFR BISPECIFIC ANTIBODY</title><date>2023-08-17</date><risdate>2023</risdate><abstract>Provided is an anti-PDL1×EGFR bispecific antibody. Experimental results show that the bispecific antibody can maintain relatively well the activity of anti-EGFR and anti-PD-L1 monoclonal antibodies; in addition, same can specifically bind to the two PD-L1 and EGFR targets at the same time, and more importantly, said bispecific antibody has obvious synergy at the cellular level.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_US2023257465A1 |
| source | esp@cenet |
| subjects | BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS VINEGAR WINE |
| title | ANTI-PDL1 x EGFR BISPECIFIC ANTIBODY |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T23%3A43%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=GU,%20Changling&rft.date=2023-08-17&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2023257465A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |